Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Quality of reported income
3Y CAGR
+14.6%/yr
vs -22.2%/yr prior
5Y CAGR
+2.7%/yr
Recent acceleration
Acceleration
+36.9pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.81 | +11.4% |
| 2024 | 0.73 | -7.0% |
| 2023 | 0.78 | +45.5% |
| 2022 | 0.54 | -27.9% |
| 2021 | 0.75 | +5.3% |
| 2020 | 0.71 | -17.4% |
| 2019 | 0.86 | -41.7% |
| 2018 | 1.47 | +75.0% |
| 2017 | 0.84 | +28.3% |
| 2016 | 0.65 | - |